SEP 05
New Users Please Click to Register
Renew or Upgrade your Existing  Account

Hypertension, Dialysis and Clinical Nephrology
VBOOTHS :  Google :  PubMed  :   Scholar  :   K/DOQI :  UpToDate :  eGFR
Slides/audio/handouts:    RRI-2015  :  Brigham-2014  :  RRI-2014  :  Brigham-2013  :  ISHD Shanghai-2013  :  ASH-2013  :  ADC-2013 (audio)  :  ASDIN-2013  :  RRI-2013  :  ISHD-HDU-Chicago-2012/14  :  Brigham-2012  :  ASH-2012  :  ADC-2012 (audio)  :  NANT-2012  :  ASDIN-2012  :  RPA-2012  :  RRI-2012  :  Brigham-2011  :  ASH-2011  :  ADC-2011  :  NANT-2011  :  ASDIN-2011  :  RPA-2011  :  RRI-2011  :  Fistula First-2010  :  ADC-2010  :  NANT-2010  :  ASDIN-2010  :  RRI-2010  :  RPA-2010  :  Network9,10-2008  : 
TalksbyDate   Search HDCN:  FreeTalks   (key):   Articles :  Abstracts :  Audiofiles :  SlideTalks :  LegacyTalks  
free ISHD Hemodialysis University Chicago (2012-2014)
free ISHD Hemodialysis University Shanghai 2013
free ISHD Hemodialysis University Chicago (2014)
free ISHD Hemodialysis University India (2014)


Harvard Brigham Nephrology Board Review Course (Part 3)   
Flash or IPAD slide/audio
Boston, MA; August 2014

Resistant and Secondary Hypertension
John P. Forman, MD





Advances in CKD 2015 (PART 5)   
Flash or IPAD slide/audio
New Orleans, LA; January 2015


PD and HD Differ in Causing End-Organ Damage
Chris W. McIntyre, MD

Children and Adolescents in CKD - Transition to Adult Therapy
Maria E. Ferris, MD

How to Prevent Hospital Readmission of Dialysis Patients?
Diane P. Wish, RN


Hypertension, Cardiovascular
CKD and stroke risk: meta
Metformin use in CKD
Prevention of CVD in type 2 DM: AHA/ADA recs
Lower systolic BP lowers risk of a. fib
Liraglutide increases weight loss in patients with DM
Idarucizumab to reverse dabigatran
Screening for cancer after venous thrombosis
Energy balance after SGLT inhibition
Standardizing research on vascular stiffness
How air pollution may increase BP: mechanism

CKD, Dialysis
Effect of frequent HD on blood pressure
High dietary acid load linked with CKD progression
Quality standards for predialysis education
Anticoagulation for HD: review
Milk intake not linked to diabetes risk or overweight
Beetroot juice fails as tx for HTN
Butter ups LDL but ups HDL, also
Mg and K linked to bone health and fracture risk
Dietary phosphate and serum P by eGFR
Extended daily HD vs. CRRT for AKI: meta
Survival on home HD vs. PD in Australia/New Zealand
Individualized dialysate cooling lowers LVM
Advanced PD solutions protect residual kidney fxn.
Microbubbles much worse with high Qb
Drug-induced albuminuria reduction protects kidney function
Prevension of a. fib with RAAS inhibitors
Hospitalizations and modality failure with home HD
Frequent nocturnal HD RCT showed higher mortality
Ferric citrate as P-binder and inflammation
Risk of mortality and pre- and post-HD pH, HCO3
PICC use ups extremity venous thrombosis risk
NSAIDS up risk of CKD
Changes to nutrition facts label
Systemic anticoagulation in ESRD (review)

Clinical Nephrology
Autoimmune-associated long QT syndrome
Patiromer and serum K in type 2 DM and CKD
Therapeutic hypothermia for deceased organ donors good
PreHTN in Mexico linked with hypomagnesemia
AJKD Atlas of Renal Pathology: FSGS
Serum K and mortality in ESRD
Pregnancy outcomes in pts. with lupus
Eculizumab reversal of dialysis-dependent CKD
Furosemide stress test and AKI severity
Urinary incontinence improved after bariatric surgery
ZS-9 K-binder helps control serum K in CKD
NSAIDS plus diuretics or RAAS inhibitors ups AKI risk
Poor transplant outcome with HCV recipient positivity

This update's selected ASN 2015 abstracts

(2015 abstracts will begin in November after the ASN)

 (Kidney Week 2014...)

News     Hit reload / refresh
RSS  Click on RSS for details of each news story.
Updated: October 09, 2015 (Oct09)
Oct09 ASN Kidney Week 2015 abstracts now available on-line
Sep25 Giving BP meds at bedtime particularly effective in lowering diabetes risk
Sep22 Japanese scientist on pathway to solving urinary excretion for stem-cell generated kidneys
Sep17 Program for "Hemodialysis University" this October 2nd and 3rd in Chicago
Sep17 Empagliflozin use in diabetes associated with large reduction in CV risk.
Sep11 SPRINT RCT data support an even lower BP target (120 systolic) for the elderly.
Sep08 Feds propose a new set of rules to protect human subjects during research.
Sep05 Multistate outbreak of salmonella linked to cucumbers.
Sep05 Aspirin found to increase sensitivity of cancer cells to immune surveillance
Sep04 Hedge fund quant proposes a disease-specific false-positive rate to FDA for drug approval.
Aug31 Spanish style mid-day "siestas" linked to lower blood pressure and better heart structure.
Aug31 Fimrenone, a selective MRA antagonist from Bayer shows promising heart failure effects.
Aug30 High blood flow rate and high negative venous pressure lead to microbubbles
Aug27 FDA approves 2nd PCSK9 inhibitor, Repatha, to lower LDL cholesterol
Aug22 Packaging medications together by date to be taken and time of day.
Aug19 Low levels of lactobacillus in the vagina associated with premature births
Aug18 Doctors will be able to look at your beating heart or at your colon in 3-D virtual reality.
Aug17 Recombinant elastase (vonapanitase) for AV fistula patency prolongation
Aug15 Hemodialysis University at Chicago, October 1-3, 2015
Aug14 Google partnering with Dexcom in continuous glucose monitoring device.
General Advances Emphasis
Effects of frequent hemodialysis on blood pressure: Results from the randomized frequent hemodialysis network trials
Dr. Kotanko and the FHN Study Group describe the effects of frequent short daily and long nocturnal HD on blood pressure. There were some surprising findings regarding the incidence of intradialytic hypotension; in the July-August issue of Hemodial Int (more...)

Considerations for systemic anticoagulation in ESRD Warfarin, dabigatran, aspirin? Watchful waiting? Other drugs? So many drugs and so little information. Dager and colleagues help guide us through the maze; in the Sept/Oct issue of Seminars in Dialysis. (more...)

Anticoagulation in chronic hemodialysis: progress toward an optimal approach
In this extremly timely review, Kessler and her colleagues discuss five key issues regarding anticoagulation: standardization, individualization, role of the extracorporeal circuit, options for heparin reduction or avoidance, and optimization of therapy; in the July/August issue of Seminars in Dialysis. (more...)

Preserving residual renal function in dialysis: what we know
Drs. Patel and Hu review what we can do at the present state of incomplete knowledge; in the May/Jun issue of Seminars in Dialysis. (more...)

Unnecessary renal replacement therapy for acute kidney injury is harmful for renal recovery
Drs. Clark and Bagshaw discuss the potential harms of dialysing patients with suspected AKI too early; in the Jan/Feb issue of Seminars in Dialysis. (more...)

Dietary protein and fiber in end stage renal disease
Tammy Sirich talks about dietary protein, fiber, gut transit time, and gut microbes in uremia, and new ways to modulate blood levels of indoxyl sulfate and p-cresyl sulfate; in the Jan/Feb issue of Seminars in Dialysis. (more...)

Thyroid function tests in end stage renal disease.
Drs. Kulkarni and Holley describe the emerging evidence that thyroid dysfunction should be sought and perhaps treated in dialysis patients; in the Nov/Dec issue of Seminars in Dialysis, which has articles about the usefulness of many other laboratory tests in ESKD as well.. (more...)

Hypomagnesemia, chronic kidney disease and cardiovascular mortality: Pronounced association but unproven causation
Dr. Dousdampanis and colleagues review the latest evidence regarding low magnesium and CKD, and whether we should treat it; in the October issue of Hemodial Int (more...)

Sailing between Scylla and Charybdis: The high serum K - low dialysate K quandary
Should we use a 3 K bath for most patients? Are 1K and zero K bath's a no-no? Drs. Labriola and Jadoul review the evidence in the Sept/Oct issue of Seminars in Dialysis. (more...)

A stepwise approach for the management of poisoning with extracorporeal treatments Few are using hemoperfusion anymore, and poisoning requires an integrated approach. Dr. Ghannoum and colleagues provide a nice overview in the July/Aug issue of Seminars in Dialysis. (more...)

Hemodialysis for infants, children, and adolescents
Drs. Kaur and Davenport review techniques for performing hemodialysis in children; in the July issue issue of Hemodial Int (more...)

Urgent-start peritoneal dialysis: what are the problems and their solutions? Dr. Mahnensmith discusses this new approach to AKI or acute-on-chronic kidney failure, its advantages and potential problems; in the May/June issue of Seminars in Dialysis. (more...)

Intradialytic hypotension: Frequency, sources of variation and correlation with clinical outcome
Dr. Sands and colleagues delve into large databases to better understand the occurrence and risk factors for intradialytic hypotension; in the April issue of Hemodial Int (more...)

  SUMMARIES of Recent Slide/Audio Symposia in reverse chronological order

  Advances in CKD (Renal Research Institute) (2015) (2014) (2013) (2012) (2011) (2010) (2009)
  Kidney Disease in Type 2 Diabetes: Disease Progression and Emerging Therapies
Philip Raskin, MD; Jennifer Marks, MD, Jerry Yee, MD, Mark Molitch, MD. (2011)
  The Brigham Renal Board Review Course: Selected Lectures (2014) -- (2013) -- (2012) -- (2011)
  American Society of Hypertension (2013)   (2012)   (2011)
  Renal Physicians Association (2012) (2011) (2010) (2009)
  American Society for Diagnostic and Interventional Nephrology (ASDIN) (2013) (2012) (2011) (2010) (2009)
  Fistula First (2010)
  Annual Dialysis Conference (audiofiles) (2012)   (2011) (2010) (2009)
  National Association of Nephrology Technologists (NANT) (2012) (2011) (2010) (2009)
  American Society for Nephrology Renal Week (2009) (2008) (2007)
  American Society for Nephrology Board Review Course (2008) (2007)
  American Society for Nephrology Renal Week (audiofiles) (2009) (2008) (2007)
  Preparing for the New Medical Director Responsibilities (Network 9/10 - RPA Special Symposium)



Site Description:
Hypertension, Dialysis, and Clinical Nephrology provides up-to-date, selected information on renal disorders and their treatment (hemodialysis, peritoneal dialysis), and about hypertension, dialysis, and clinical nephrology topics.
Hypertension, Dialysis, and Clinical Nephrology is a place for physicians and nurses who treat patients with kidney or renal disease. Here physicians and nurses can find answers to frequently asked hypertension, dialysis, and nephrology questions (FAQ), pointers to recent review articles, and summaries of hot new hypertension, dialysis, and nephrology papers, abstracts, and meeting presentations. Also, information about medical products, devices, services, and drugs pertaining to hypertension, dialysis, and clinical nephrology are provided, as is a list of links to relevant hypertension / dialysis / transplantation organizations, medical provider networks, and databases. Much of the information presented is collected from a distinguished editorial board composed of specialists in the field of kidney or renal disease.

The information at this server is provided with the understanding that the publisher, authors, and advisors are not rendering medical or medical professional services. Medicine is a rapidly changing area, and efforts have been made to provide information that is medically correct at the time of publication. However, there may be mistakes, both typographical and in content. The material provided should be used only as a general guide and not the ultimate source of information. The material should not be used to form the basis of personal or professional decisions. The authors, advisors, and publisher shall have neither liability not responsibility to any person or entity with respect to any loss or damage alleged to be caused directly or indirectly by the information presented on this server.

Copyright statement:
Disclaimer: The reader is responsible for discerning the validity, factuality or implications of information posted here. The content of posts on this site, including but not limited to links to other web sites, are the expressed opinion of the original poster and are in no way representative of or endorsed by the owners or administration of this website. The posts on this website are the opinion of the specific author and are not statements of advice, opinion, or factual information on behalf of the owner or administration of HDCN or Medtext, Inc. This site is provided "as is" without warranty of any kind, either expressed or implied. You should not assume that this site is error-free or that it will be suitable for the particular purpose which you have in mind when using it. In no event shall hdcn.com or Medtext, Inc. be liable for any special, incidental, indirect or consequential damages of any kind, or any damages whatsoever, including, without limitation, those resulting from loss of use, data or profits, whether or not advised of the possibility of damage, and on any theory of liability, arising out of or in connection with the use or performance of this site or other documents which are referenced by or linked to this site. Fair Use Notice: This site may contain copyrighted material the use of which has not always been specifically authorized by the copyright owner. Users may make such material available in an effort to advance awareness and understanding of issues relating to civil rights, economics, individual rights, international affairs, liberty, science & technology, etc. We believe this constitutes a 'fair use' of any such copyrighted material as provided for in section 107 of the US Copyright Law. In accordance with Title 17 U.S.C.Section 107, the material on this site is distributed to those who have expressed a prior interest in receiving the included information for research and educational purposes. In accordance with industry accepted best practices we ask that users limit their copy / paste of copyrighted material to the relevant portions of the article you wish to discuss and no more than 50% of the source material, provide a link back to the original article and provide your original comments / criticism in your post with the article. Please remember YOU are responsible for what YOU post on the internet and YOU could be sued by the original copyright holder if you do not honor these rules. If you are a legal copyright holder or a designated agent for such and you believe a post on this website falls outside the boundaries of "Fair Use" and legitimately infringes on yours or your clients copyright we may be contacted concerning copyright matters at: Medtext, Inc. 15W560 89th Street Willowbrook, IL 60527 tel: 630-325-3276 email: editor -at sign- hdcn.com If you require a courier address please send a fax or email and we will provide you with the required information. In accordance with section 512 of the U.S. Copyright Act our contact information has been registered with the United States Copyright Office. "Safe Harbor" noticing procedures as outlined in the DMCA apply to this website concerning all 3rd party posts published herein. If notice is given of an alleged copyright violation we will act expeditiously to remove or disable access to the material(s) in question. It is our strict policy to disable access to accounts of repeat copyright violation offenders. We will also ban the IP address of repeat copyright violators from future posting on this website with or without a registered account. All 3rd party material posted on this website is copyright the respective owners / authors. hdcn.com makes no claim of copyright on such material. For more information please visit: http://www.law.cornell.edu/uscode/17/107.shtml

Published by Medtext, Inc., Willowbrook, IL, 630-325-3276
E-mail to: editor (at sign) hdcn.com

96 97 98 99